Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cannara Biotech Inc. V.LOVE

Alternate Symbol(s):  LOVFF

Healthcare Cannabis
Cannara Biotech Inc. is a Canada-based vertically integrated producer of premium-grade cannabis and cannabis-derivative products for the Quebec and Canadian markets. It operates through its wholly owned subsidiaries, Cannara Biotech (Quebec) Inc. and Cannara Biotech (Valleyfield) Inc. The Company owns two mega facilities based in Quebec spanning over 1,650,000 square feet, providing the Company with 100,000 kilograms of annualized cultivation output. It operates in two segments: Cannabis operations and Real estate operations. The Cannabis operations, which encompasses the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and other cannabis services (Cannabis operations). The Real estate operations, related to the Farnham and Valleyfield building (Real estate operations). The Company’s brand portfolio includes Tribal, Nugz, and Orchid CBD. Orchid CBD is a wellness brand that provides premium CBD-dominant cannabis.


TSXV:LOVE - Post by User

Cannara Biotech Inc.
Bullboard Posts
User Avatar Image
(1)
•••
Post by Sunjamon Jan 23, 2019 11:30pm
231 Views
Post# 29274023

I bought HUGE at .12

I bought HUGE at .12Sold half at .86. Probably shoulda sold it all but I'll hold my remaining shares and see what happens when they get their license. Now I'm researching Cannara. I'm big on indoor growth and that massive building they own is 45 mins from Montreal. That's all they got right now but it's something. That and the aggressive build out... The potential is obvious and FSD Pharma (HUGE) owns a portion of them. Pot grown indoors versus greenhouse is vastly superior but they're young and no license for a while. Then again, HUGE ran on speculation and without a license from .08 to .88. Driven by greed and volume before they even planted a seed. Proof it can happen here too. I'm on the sidelines still though. FYI the bashers are buying in at the low too, I'm just honest about my position and not claiming to know where the bottom is; no one has a clue what'll be. Those that do are delusional! Just the facts ma'am.

First thing they need to do though is change that ticker, it's ridiculous. 

https://www.newswire.ca/news-releases/fsd-pharma-inc-announces-a-partnership-agreement-with-cannara-biotech-inc-to-allow-for-indoor-grow-space-to-increase-to-a-combined-1245000-square-feet-685914562.html

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities